ICD-10 code O28.1: Abnormal biochemical finding on antenatal screening

Key Takeaways

ICD-10 code O28.1 is a billable, HIPAA-valid diagnosis code for an abnormal biochemical finding on antenatal screening of mother, effective October 1, 2025.

Common biochemical markers documented under O28.1 include AFP (alpha-fetoprotein), hCG, PAPP-A, estriol, and inhibin A from first- and second-trimester screening panels.

O28.1 is POA (Present on Admission) exempt and must not be coded when diagnostic abnormal findings are classified elsewhere (Type 1 Excludes).

Pabau’s claims management software helps OB/GYN practices submit O28.1 claims accurately with built-in documentation workflows and digital intake forms.

ICD-10 code O28.1 is a billable, HIPAA-valid diagnosis code for an abnormal biochemical finding on antenatal screening of mother. It applies when a first-trimester combined screen or second-trimester quad screen returns an out-of-range result for a marker such as AFP, hCG, or PAPP-A, and the provider documents the finding.

This guide covers the code’s clinical meaning, documentation requirements, related codes, and the most common coding errors OB coders encounter.

ICD-10 code O28.1: Definition and clinical description

ICD-10 code O28.1 represents an abnormal biochemical finding on antenatal screening of mother. It belongs to Chapter 15 (Pregnancy, childbirth and the puerperium, O00-O9A) of the ICD-10-CM classification, under the block O20-O29 (Other maternal disorders predominantly related to pregnancy) and the parent category O28 (Abnormal findings on antenatal screening of mother).

Practices using OB/GYN practice management software can attach this code directly to the encounter record at the time the abnormal result is documented.

The clinical scenario this code captures: A pregnant patient undergoes a routine biochemical screening panel, one or more markers fall outside reference ranges for gestational age, and the provider documents the finding.

The code applies regardless of which specific marker triggered the abnormal result, as long as the finding is biochemical in nature rather than hematological (O28.0), cytological (O28.2), chromosomal (O28.5), or ultrasound-based (O28.3).

O28.1 code details at a glance

The table below captures the key administrative facts coders need before submitting a claim with ICD-10 code O28.1. Verifying these details against your payer’s LCD before submission reduces the risk of denials on obstetric claims. For a broader look at HIPAA compliance in medical offices, including claim submission requirements, see our dedicated guide.

Prenatal biochemical screening tests covered by O28.1

The O28.1 code applies when any biochemical marker from an antenatal panel returns an abnormal result. The most common panels generating this code are the first-trimester combined screen and the second-trimester quad screen. Cell-free DNA testing (NIPT) screens for chromosomal abnormalities rather than biochemical markers, so an abnormal cfDNA result is coded as O28.5, not O28.1.

Practices running fertility clinic software alongside their obstetric workflows often see these panels ordered in coordination with reproductive endocrinologists during early pregnancy surveillance.

Key biochemical markers documented under O28.1 include the following. Per ACOG clinical guidance, specific numerical thresholds for “abnormal” vary by laboratory and gestational age; coders should rely on the provider’s documented interpretation rather than lab reference ranges.

O28.1 vs other O28 subcategory codes

Selecting the correct O28 subcode requires knowing the type of screening that produced the abnormal result. Choosing O28.9 (unspecified) when the record clearly supports O28.1 is one of the most common accuracy failures in obstetric coding.

The table below outlines the full O28 category so coders can quickly identify the right level of specificity. The same specificity principle applies to labor and delivery coding, covered in our guide to O76.

Type 1 excludes and coding notes

The parent category O28 carries a Type 1 Excludes note that applies directly to O28.1. A Type 1 Excludes note means the excluded codes cannot be used together with O28.1; they represent mutually exclusive conditions.

According to the CMS ICD-10-CM coding resources, Type 1 Excludes restrictions are among the most frequently violated coding rules in obstetric claims.

• Excluded from O28.1: Diagnostic abnormal findings classified elsewhere in ICD-10-CM. When the abnormal biochemical result has been further investigated and a specific condition identified (e.g., confirmed chromosomal abnormality coded to O28.5, or a confirmed fetal anomaly coded elsewhere), use the more specific code rather than O28.1.
• Not excluded: Using O28.1 alongside a principal obstetric diagnosis code (e.g., a routine antenatal care code from Z34) when the biochemical finding is a secondary, screening-detected result not yet diagnosed as a specific condition.
• POA exempt status: O28.1 is exempt from Present on Admission reporting, consistent with standard ICD-10-CM rules for obstetric diagnoses. No POA indicator is required when submitting this code on inpatient claims.

Documentation requirements for ICD-10 code O28.1

Payer audits on obstetric screening codes most often target incomplete documentation rather than code selection errors. Three elements must appear in the medical record to support ICD-10 code O28.1 on a claim. OB/GYN practices using claims management software can build these requirements directly into their encounter templates, reducing the chance of a denial at submission.

1. The screening test ordered: The chart must show which biochemical panel was performed (e.g., first-trimester combined screen, quad screen). The order, lab requisition, or clinical note referencing the test name satisfies this requirement.
2. The result flagged as abnormal: A lab report showing an out-of-range marker value is necessary. The specific marker (AFP, hCG, PAPP-A) and the nature of the abnormality should be identifiable from the result slip or a clinical summary.
3. Provider acknowledgement: The clinician’s note must explicitly acknowledge the abnormal biochemical finding. A result slipped into the chart without a physician or midwife notation does not support the diagnosis. A phrase such as “abnormal first-trimester biochemical screen noted; patient counseled” meets the documentation threshold. Digital intake forms and structured clinical templates help ensure this notation is captured consistently.

Consistent documentation across every encounter reduces audit risk. For broader guidance on medical documentation best practices in clinical settings, our dedicated resource covers the workflow considerations in detail.

Common coding errors and how to avoid them

Only one of the four major ICD-10 reference sites in this code’s SERP covers coding errors for O28.1 in any depth, which means practices relying on standard lookup tools are missing actionable pitfall guidance. The three errors below account for the majority of obstetric screening denials and compliance flags related to O28.1.

The same sequencing and specificity issues show up in other obstetric diagnosis codes, including O71.9.

• Using O28.9 (unspecified) when O28.1 is supported. If the lab report identifies a biochemical marker as the abnormal finding and the provider acknowledges it, O28.1 is the correct code. Defaulting to O28.9 because the coder is uncertain signals a documentation review issue, not a coding default. O28.9 is only valid when the type of abnormal finding genuinely cannot be determined from the record.
• Confusing O28.1 with O28.5. Biochemical screening results, even when they suggest chromosomal risk, do not become O28.5 until a chromosomal or genetic abnormality is confirmed by diagnostic testing (karyotype, amniocentesis, CVS). An elevated risk ratio from a quad screen remains O28.1 until diagnosis is confirmed.
• Coding without documented provider acknowledgement. A lab result in the chart without a clinician note referencing it is not sufficient. Some EHR systems auto-populate results but do not auto-generate the provider’s clinical acknowledgement. Verify that the encounter note contains an explicit reference to the abnormal biochemical finding before assigning O28.1.
• Coding a specific condition instead of the screening finding. When the abnormal biochemical result triggers further testing and a specific fetal or maternal condition is confirmed, that condition should be coded rather than O28.1. The screening-finding code is for the period before a definitive diagnosis is established.

Connecting your patient records system to a structured billing workflow reduces the risk of these errors reaching the claim stage. When providers and coders work from the same encounter data, the documentation-to-claim chain stays intact.

ICD-9-CM to ICD-10-CM crosswalk for O28.1

Practices reconciling historical claims or transitioning legacy data need to map O28.1 back to its ICD-9-CM predecessor. According to ResDAC Medicare files guidance, crosswalks between ICD-9 and ICD-10 are approximate. Coders should verify against the CMS General Equivalence Mappings (GEMs) files when making coding decisions for historical data analysis or legacy billing reconciliation.

The same ICD-9-to-ICD-10 crosswalk approach applies across diagnostic categories, as shown in our guide to M34.9.

Note: ICD-9-CM crosswalks for obstetric screening codes are approximate. The ICD-10-CM O28 category introduced subcategory specificity that did not exist under ICD-9-CM. Verify specific mappings against the CDC/NCHS ICD-10-CM web tool and CMS GEMs files before using crosswalk data for billing or research purposes.

CPT codes commonly billed alongside O28.1

Complete claim submission for antenatal biochemical screening typically pairs O28.1 with one or more CPT procedure codes. Pairing errors, such as the wrong CPT for the panel ordered or a missing genetic counseling code, are a secondary cause of claim denials on these encounters.

Verify pairings against your payer’s LCD before submission, as coverage varies. Practices managing high-volume antenatal billing benefit from practice management software that links diagnosis and procedure codes at the encounter level.

Streamline obstetric billing from screening to claim

Pabau helps OB/GYN and women's health practices link diagnosis codes, procedure codes, and clinical documentation in a single workflow. Reduce claim errors and keep your obstetric records audit-ready.

Book a demo

O28.1 synonyms and lay terms

The following approximate synonyms appear in ICD-10-CM coding references for O28.1. These terms may appear in clinical notes or patient-facing documentation and should be mapped to O28.1 when the underlying finding is a biochemical antenatal screening abnormality.

• Abnormal biochemical result on antenatal screening
• Abnormal prenatal biochemical screen
• Abnormal maternal serum screening result
• Abnormal first-trimester biochemical screen
• Abnormal quad screen (biochemical components)
• Elevated or low AFP on antenatal screening
• Abnormal PAPP-A on prenatal screen
• Abnormal hCG on antenatal screening

Conclusion

Most obstetric coding errors around ICD-10 code O28.1 trace back to one of three issues: wrong specificity within the O28 category, absent provider acknowledgement in the chart, or premature upgrade to O28.5 before a chromosomal diagnosis is confirmed. Getting this right at the documentation stage prevents denials before they reach the clearinghouse.

Pabau’s claims management software helps OB/GYN teams build structured encounter templates that capture every documentation element O28.1 requires. Book a demo to see the full workflow in action.

Continue your research

Need a similar specificity breakdown for another obstetric code? N85.3 covers documentation requirements for uterine subinvolution in a similar reference format.

Managing antenatal documentation across multiple practitioners? Medical forms guide covers structured documentation workflows that keep clinical records audit-ready.

Managing delivery planning alongside antenatal screening? VBAC birth plan template helps practices document prior cesarean history and delivery preferences.

Frequently asked questions